Article
Clinical hallmarks and genetic polymorphisms in the CFTR gene contribute to the disclosure of the A1006E mutation.
Clinical and investigative medicine. Medecine clinique et experimentale - 1 Aug 2010
Tomaiuolo Anna Cristina, Alghisi Federico, Petrocchi Stefano, Surace Cecilia, Roberti Maria Cristina, Bella Sergio, Lucidi Vincenzina, Angioni Adriano
Abstract excerpt
Since the identification of the Cystic Fibrosis transmembrane conductance regulator (CFTR) gene in 1989, many genetic mutations have been found in cystic fibrosis (CF) patients. Dysfunctions of the CFTR gene are responsible for the highly variable clinical presentation ranging from severe CF, disseminated bronchiectasis, idiopathic chronic pancreatitis and congenital bilateral absence of vas deferens (CBAVD)....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
